Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor

被引:241
|
作者
AbuAmer, Y [1 ]
Ross, FP [1 ]
Edwards, J [1 ]
Teitelbaum, SL [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DEPT PATHOL, BARNES JEWISH HOSP N, ST LOUIS, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 100卷 / 06期
关键词
bone resorption; periodontitis; tumor necrosis factor receptor; thalidomide; bone marrow macrophages;
D O I
10.1172/JCI119679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF, Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS, An anti-TNF antibody blacks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro, Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo, In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor, Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [21] Tumor necrosis factor-α soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women
    Sanchez, SE
    Zhang, CL
    Williams, MA
    Ware-Jauregui, S
    Larrabure, G
    Bazul, V
    Farrand, A
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 47 (01) : 49 - 63
  • [22] CLONING AND PARTIAL CHARACTERIZATION OF THE PROMOTER FOR THE HUMAN P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR
    KEMPER, O
    WALLACH, D
    GENE, 1993, 134 (02) : 209 - 216
  • [23] INTERFERON-ALPHA INDUCES CIRCULATING TUMOR-NECROSIS-FACTOR RECEPTOR P55 IN HUMANS
    TILG, H
    VOGEL, W
    DINARELLO, CA
    BLOOD, 1995, 85 (02) : 433 - 435
  • [24] A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway
    Adam, D
    Wiegmann, K
    AdamKlages, S
    Ruff, A
    Kronke, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14617 - 14622
  • [25] DIAGNOSTIC VALUE OF DETERMINATION OF SOLUBLE RECEPTOR OF TUMOR NECROSIS FACTOR P55 IN URINE AT THE BLADDER CANCER
    Shishlo, L. M.
    Prokhorova, V. I.
    Derzhavets, L. A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S271 - S271
  • [26] Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense
    Chiu, H
    Gardner, CR
    Dambach, DM
    Brittingham, JA
    Durham, SK
    Laskin, JD
    Laskin, DL
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 285 (05): : G959 - G966
  • [27] Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level
    Rebel, VI
    Hartnett, S
    Hill, GR
    Lazo-Kallanian, SB
    Ferrara, JLM
    Sieff, CA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10): : 1493 - 1503
  • [28] Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo
    Speiser, DE
    Sebzda, E
    Ohteki, T
    Bachmann, MF
    Pfeffer, K
    Mak, TW
    Ohashi, PS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) : 3055 - 3060
  • [29] Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis
    Naveau, S
    Abella, A
    Raynard, B
    Balian, A
    Giraud, V
    Montembault, S
    Mathurin, P
    Keros, LG
    Portier, A
    Capron, F
    Emilie, D
    Galanaud, P
    Chaput, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (12): : 3361 - 3367
  • [30] Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
    Gary, DS
    Bruce-Keller, AJ
    Kindy, MS
    Mattson, MP
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (12): : 1283 - 1287